Literature DB >> 21971868

Tiam1, overexpressed in most malignancies, is a novel tumor biomarker.

Bin Chen1, Yi Ding, Feiye Liu, Jian Ruan, Jian Guan, Jing Huang, Xianghua Ye, Shuang Wang, Gong Zhang, Xiangmei Zhang, Zhao Liang, Rongcheng Luo, Longhua Chen.   

Abstract

T lymphoma invasion and metastasis 1 (Tiam1) is a guanine nucleotide exchange factor (GNEF) family member, and is considered to be involved in many important cellular processes and oncogenesis. In this study, we investigated Tiam1 expression differences between normal tissue and malignant tissue using tissue microarray (TMA), and further studied the Tiam1 mRNA and protein level in 9 hepatoma lines. Forty-nine tumor tissue and 47 normal tissue samples were detected via TMA by immunohistochemistry with polyclonal antibody. Tiam1 expression in 9 human hepatoma cell lines, namely Huh-7, HepG2, Hep3B, SMMC-7721, QGy-7701, QGy-7703, BEL-7402, BEL-7404 and BEL-7405, and 1 normal primary human hepatocyte, HL-7702, was compared by means of fluorescence quantitative PCR, immunocytochemistry assay and Western blotting. We found that Tiam1 was significantly expressed in various malignancies. Tiam1 mRNA and protein levels were significantly elevated in the 9 human hepatoma cell lines compared to the normal primary human hepatocyte. Our results suggest that Tiam1 overexpression in malignant neoplasms could be a novel effective supplementary biomarker for tumors, including hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21971868     DOI: 10.3892/mmr.2011.612

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  9 in total

1.  Rab5 is required in metastatic cancer cells for Caveolin-1-enhanced Rac1 activation, migration and invasion.

Authors:  Jorge Díaz; Pablo Mendoza; Rina Ortiz; Natalia Díaz; Lisette Leyton; Dwayne Stupack; Andrew F G Quest; Vicente A Torres
Journal:  J Cell Sci       Date:  2014-03-21       Impact factor: 5.285

2.  Biological effects of RNAi targeted inhibiting Tiam1 gene expression on cholangiocarcinoma cells.

Authors:  Wei Cheng; Yaling Liu; Zhi Zuo; Xinmin Yin; Bo Jiang; Daojin Chen; Chuang Peng; Jianhui Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

3.  MicroRNA-377 suppresses cell proliferation and invasion by inhibiting TIAM1 expression in hepatocellular carcinoma.

Authors:  Guolin Chen; Lu Lu; Chang Liu; Lei Shan; Di Yuan
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

4.  The Downregulation of MiR-182 Is Associated with the Growth and Invasion of Osteosarcoma Cells through the Regulation of TIAM1 Expression.

Authors:  Jun Hu; Guohua Lv; Shuguang Zhou; Yucheng Zhou; Bangxu Nie; Hong Duan; Yunfeng Zhang; Xiaofeng Yuan
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

5.  Tumor PHD2 expression is correlated with clinical features and prognosis of patients with HCC receiving liver resection.

Authors:  Li Zhen; Ning Shijie; Zhang Shuijun
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

6.  Recruitment of Tiam1 to Semaphorin 4D Activates Rac and Enhances Proliferation, Invasion, and Metastasis in Oral Squamous Cell Carcinoma.

Authors:  Hua Zhou; Maricel G Kann; Emily K Mallory; Ying-Hua Yang; Amr Bugshan; Nada O Binmadi; John R Basile
Journal:  Neoplasia       Date:  2016-12-27       Impact factor: 5.715

7.  Afatinib, an EGFR inhibitor, decreases EMT and tumorigenesis of Huh‑7 cells by regulating the ERK‑VEGF/MMP9 signaling pathway.

Authors:  Yafei Chen; Xin Chen; Xiaojun Ding; Yingwei Wang
Journal:  Mol Med Rep       Date:  2019-08-06       Impact factor: 2.952

8.  The Identification of Key Gene Expression Signature and Biological Pathways in Metastatic Renal Cell Carcinoma.

Authors:  Lin Bao; Ye Zhao; ChenChen Liu; Qi Cao; Yu Huang; Ke Chen; Zhengshuai Song
Journal:  J Cancer       Date:  2020-01-16       Impact factor: 4.207

9.  Systematic investigation of promoter substitutions resulting from somatic intrachromosomal structural alterations in diverse human cancers.

Authors:  Babak Alaei-Mahabadi; Kerryn Elliott; Erik Larsson
Journal:  Sci Rep       Date:  2020-10-23       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.